Descrease article font size Increase article font size Health Canada on Thursday approved another respiratory syncytial virus (RSV) vaccine for adults over the age of 60 and pregnant people. Pfizer’s bivalent RSV vaccine, Abrysvo, has been authorized for the use of pregnant individuals from 32 through 36 weeks gestational age for …
Read More »Health Canada approves Pfizer’s new bivalent COVID-19 vaccine
Health Canada has approved Pfizer’s new bivalent COVID-19 vaccine, which targets the virus strains now most common in Canada. The updated version of the Pfizer-BioNTech Comirnaty COVID-19 vaccine targets the Omicron BA.4 and BA.5 subvariants, as well as the original strain of the virus, and is authorized for use as a booster dose in …
Read More »pfizer covid vaccine: Researchers urge delay in administering second dose of Pfizer’s Covid-19 vaccine, cite strong data
Two Canada-based researchers on Wednesday urged governments to delay administering the second dose of Inc’s COVID-19 vaccine, which they said had an efficacy of 92.6% after the first dose, as it was not significantly beneficial in the short term. Danuta Skowronski and Gaston De Serres said their findings were derived …
Read More »